反应详情

The title compound was prepared analogously to step 4 from Example A(97) where 1-{4-[3-Cyclopentyl-4-(2,2-dimethyl-6-oxo-6H-[1,3]dioxin-4-yl)-3-hydroxy-but-1-ynyl]-2-fluoro-phenyl}-cyclopentanecarbonitrile (from step 2 below) was substituted in place of 2-{4-[3-cyclopentyl-4-(2,2-dimethyl-4-oxo-4H-1,3-dioxin-6-yl)-3-hydroxybut-1-ynyl]-2-fluorophenyl}-2-methylpropanenitrile. 1H NMR (CDCl3) δ: 1.18–1.74 (m, 16 H), 1.92–2.17 (m, 2 H), 2.5–2.52 (m, 1 H), 2.66–2.68 (m, 2 H), 2.77 (s, 2 H), 3.43 (s, 2 H), 6.89–6.94 (m, 2 H), 7.33–7.37 (m, 1 H). MS (ESI): 398 (M+H)+.